INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
18
SC
Syrvalin Kristine CEVP General Counsel
MTUSMetallus Inc.
Open-market sale · 10b5-1 plan
SELL$102K
4,643 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

Page 24 of 508
← PrevNext →
18
OJ
O Connor Kevin JDirector
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL
$6,713
110 sh
Nov 3, 2026
Nov 4, 2026
traded Nov 3, 2026
+1d
SEC Form 4

Evidence

18
FL
Felice Laura L.EVP, Chief Financial Officer
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$251K
2,320 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$101K
2,816 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
PC
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1.80M
20.0K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

18
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
3,241 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

18
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$86K
2,393 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$6.71M
133.3K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$92K
1,295 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$8.81M
174.9K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Open-market sale
SELL$8,738
660 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
WY
Wassenaar YvonneDirector
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
721 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

17
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.34M
29.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
HL
Hendry Gregory LChief Accounting Officer
PMTPennyMac Mortgage Investment Trust
Open-market sale · 10b5-1 plan
SELL$19K
2,443 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
SF
Stat Lauren Elaina FriedmanDirector
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$253K
1,358 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$56K
840 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
PE
Palmer Benjamin EdwardSVP, Pres Commercial
VSATVIASAT INC
Open-market sale · 10b5-1 plan
SELL$154K
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

17
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$3.06M
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
BJ
Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$357K
1,160 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$100K
240 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$1.43M
93.3K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$81K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$166K
408 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
KJ
Kasbar Michael JDirector, Executive Chairman
WKCWORLD KINECT CORP
Open-market sale · 10b5-1 plan
SELL$292K
8,062 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
SR
Swanson Luke RoyCHIEF TECHNOLOGY OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
3,094 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
317 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$172K
6,700 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$150K
2,738 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$172K
6,700 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
SR
Swanson Luke RoyCHIEF TECHNOLOGY OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$212K
3,283 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$213K
520 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
DM
Daspit MarisaCHIEF PEOPLE OFFICER
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
720 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale · 10b5-1 plan
SELL$172K
6,700 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$164K
410 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$118K
295 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$184K
470 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$134K
334 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

16
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
1,129 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

16
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Open-market sale · 10b5-1 plan
SELL$373K
11.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence